SII seeks inclusion of COVID jab Covovax in CoWIN portal as heterologous booster dose for adults Read more
DCGI approves market authorisation for SII’s COVID vaccine Covovax as heterologous booster dose Read more
Serum Institute seeks drug regulator’s approval for market authorisation of its COVID vaccine as booster dose Read more
DCGI panel to review today SII applications for Covovax’s use among kids aged 2-7 years, 7-11 years Read more